Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM), Sydney, 2024.
Recently available treatment data on hep C through to October 2023. An assessment of ongoing trends from 2016, including the apparent health service impact of the ongoing COVID-19 pandemic and associated restrictions is also presented.
Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM), Sydney, 2024. 138p.
Includes data regarding hep B, as well as estimates of viral hepatitis testing and liver cancer. With recent available estimates for prevalence, treatment and care of hep B to the end of 2022, with testing data available to the end of 2023.
Hepatitis Australia, Canberra, 2024. 4p.
Useful statistics and information about hepatitis B and C in Australia – originally designed for World Hepatitis Day communications. Available in Arabic, Chinese (simplified and traditional), English and Vietnamese.
Kirby Institute, Sydney, 2024.
Evaluates progress towards hep C elimination in NSW, aligning with state, national, and global elimination strategies and assesses trends in testing, treatment, and prevention measures, incidence, morbidity, and mortality.
World Health Organization, Geneva, 2024. 81p.
This publication summarizes the approach proposed by WHO to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the subnational, national and global levels.
Aust Institute of Health & Welfare, Canberra, 2024. 3xreports
A mix of short statistical summaries and long-form articles exploring topical health issues. Australia’s health also serves as a ‘report card’ on the health of Australians by looking at how we are faring as a nation.
MDPI, Basel, 2024. 13p.
Identifies ways to improve hep C testing in hospital inpatients, particularly in EDs, via a study of patients at a regional hospital in Victoria, who inject drugs or are living with hep C.
International Journal for Equity in Health (via BioMed Central), London, 2024. 24p.
Findings underscore the need for tailored strategies that address stigma, improve provider roles and communication, and foster an inclusive environment for equitable HCV care.
Int Journal of Drug Policy (via Elsevier), London, 2024. 5p. extended abstract.
HCV RNA PoCT led to a significantly higher proportion of clients attending a supervised injecting facility engaging in hepatitis C testing, whilst also reducing the time to treatment initiation.
Pharmaceutical Society of Australia, Canberra, 2024. 7:35 minute video.
2 experts share practical tips for pharmacists on bolstering testing and treatment (especially clients on relevant medications e.g. Opioid Agonist Therapy) to prevent unnecessary infections, complications and deaths.
BMC public Health, London, 2024. 10p.
Analysis of 14 peer-reviewed articles underscored the need for nuanced approaches to addressing vaccine hesitancy among religious groups.
NDARC, Sydney, 2024. 1p.
The aim of this bulletin is to describe the sexual health behaviours among a group of PWID interviewed in Australia in 2023.
Int Network on Hepatitis in Substance Users (INHSU), Zurich, 2024. Video 1 minute
In this short film, Nurse Mim O'Flynn from Kombi Clinic, discusses the issue of loss of follow-up with people experiencing homelessness.
Medical News Today, Bexhill-on-Sea, 2023. 5p.
Discusses the potential benefits of ginger for individuals with diabetes, as well as possible side effects. While more research is necessary, some evidence suggests ginger may help manage blood sugar levels.
CDC Foundation, Atlanta, 2023. 19p.
Explores how arts and culture have been utilized to promote vaccine confidence, dispel myths and misinformation surrounding vaccines and support vaccination efforts in the United States.
Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM), Sydney, 2024 (rev). 10p.
Guidance for clinicians to support people living with hepatitis B in the process of applying for a permanent visa.
BMC Pubic Health, London, 2024. 8p.
Aims to describe the lived experience of discrimination, document its impact, and shed light on its consequences via a hepatitis B discrimination registry launched to record self-reported discrimination.
ASHM, Sydney, 2024. 6p.
A multi-faceted project covering hepatitis case-finding, workforce training, and in-language public education for people living with chronic hep B and the Aboriginal health workforce.
Int. Journal of Drug Policy , London, 2024. 12p.
Aimed to quantify differences in testing, treatment, and current HCV infection between men and women who inject drugs including those who were homeless.
The Lancet, London, 2024. 11p.
The Hep B PAST is an effective model of care that aims to improve health outcomes for First Nations people living with chronic hep B.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.